A new University of Missouri study reveals that artificial intelligence can significantly improve the accuracy of cardiac risk prediction, potentially revolutionizing personalized heart care. Researchers, led by Fares Alahdab, MD, MS, MSc, FAHA, utilized machine learning to analyze positron emission tomography (PET) scans of patients with heart disease, identifying those at highest risk of a major adverse cardiac event, or MACE. “Our model assigned patient risk of MACE more accurately than other predictive models that interpret data,” said Alahdab, associate professor at the Mizzou School of Medicine. Published ahead of print in the Journal of Nuclear Cardiology on January 28, 2026, this advancement overcomes limitations of traditional statistical analysis, offering the potential to optimize individual treatment plans and improve patient quality of life.
PET Scan Data Improves MACE Risk Prediction Accuracy
This advance promises to move beyond the limitations of traditional statistical analyses currently used to predict outcomes like rehospitalization risk. The new model’s strength lies in its ability to process complex datasets and variable relationships, exceeding the capabilities of conventional approaches. Alahdab notes, “We trained our model on information from advanced nuclear scans of patients with coronary artery disease, and some of these methods can be applicable to other diseases as well.” Identifying high-risk individuals is paramount for tailoring treatment plans and enhancing patient quality of life, a goal underscored by the study’s findings; “Identifying patients most at-risk for adverse health events is crucial for personalizing their care plan and maintaining their quality of life,” said Alahdab.
Machine Learning Model Overcomes Limitations of Traditional Assessments
Traditional methods of predicting cardiac risk, often relying on statistical analysis, are now facing a challenge from artificial intelligence. This new approach sidesteps inherent constraints of conventional assessments, which struggle with both data volume and complex variable interactions. The findings were recently published in the Journal of Nuclear Cardiology.
“Our model assigned patient risk of MACE more accurately than other predictive models that interpret data,” study author Fares Alahdab said. “This can help optimize individual care for the patient.”
Fares Alahdab, MD, MS, MSc, FAHA
